FDA inspection
Bowil Biotech Sp. z.o.o. (Ltd.): FDA inspection ending Sep 18, 2025
FDA inspection 1283234 · Voluntary Action Indicated (VAI) · Wladyslawowo
Key facts
| Inspection ID | 1283234 |
|---|---|
| Firm | Bowil Biotech Sp. z.o.o. (Ltd.) |
| FEI number | 3012479318 |
| Address | Ulica Skandynawska 7, Street |
| City | Wladyslawowo |
| Country | Poland |
| Fiscal year | 2025 |
| Inspection end date | Sep 18, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data